nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—migraine—Prednisone—atopic dermatitis	0.798	1	CpDpCtD
Frovatriptan—Arrhythmia—Hydrocortisone—atopic dermatitis	0.000184	0.000943	CcSEcCtD
Frovatriptan—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000184	0.000939	CcSEcCtD
Frovatriptan—Mental disorder—Hydrocortisone—atopic dermatitis	0.000181	0.000925	CcSEcCtD
Frovatriptan—Malnutrition—Hydrocortisone—atopic dermatitis	0.00018	0.000919	CcSEcCtD
Frovatriptan—Bradycardia—Dexamethasone—atopic dermatitis	0.000179	0.000918	CcSEcCtD
Frovatriptan—Bradycardia—Betamethasone—atopic dermatitis	0.000179	0.000918	CcSEcCtD
Frovatriptan—Haemoglobin—Betamethasone—atopic dermatitis	0.000177	0.000906	CcSEcCtD
Frovatriptan—Haemoglobin—Dexamethasone—atopic dermatitis	0.000177	0.000906	CcSEcCtD
Frovatriptan—Haemorrhage—Dexamethasone—atopic dermatitis	0.000176	0.000902	CcSEcCtD
Frovatriptan—Haemorrhage—Betamethasone—atopic dermatitis	0.000176	0.000902	CcSEcCtD
Frovatriptan—Nausea—Mometasone—atopic dermatitis	0.000175	0.000897	CcSEcCtD
Frovatriptan—Arrhythmia—Triamcinolone—atopic dermatitis	0.000174	0.000888	CcSEcCtD
Frovatriptan—Arrhythmia—Methylprednisolone—atopic dermatitis	0.000173	0.000886	CcSEcCtD
Frovatriptan—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000173	0.000886	CcSEcCtD
Frovatriptan—Ill-defined disorder—Prednisolone—atopic dermatitis	0.000171	0.000873	CcSEcCtD
Frovatriptan—Depression—Prednisone—atopic dermatitis	0.000171	0.000872	CcSEcCtD
Frovatriptan—Visual impairment—Betamethasone—atopic dermatitis	0.00017	0.000869	CcSEcCtD
Frovatriptan—Visual impairment—Dexamethasone—atopic dermatitis	0.00017	0.000869	CcSEcCtD
Frovatriptan—Mental disorder—Methylprednisolone—atopic dermatitis	0.00017	0.000869	CcSEcCtD
Frovatriptan—Malnutrition—Methylprednisolone—atopic dermatitis	0.000169	0.000863	CcSEcCtD
Frovatriptan—Asthenia—Tacrolimus—atopic dermatitis	0.000169	0.000862	CcSEcCtD
Frovatriptan—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000169	0.000862	CcSEcCtD
Frovatriptan—Myocardial infarction—Prednisone—atopic dermatitis	0.000168	0.000857	CcSEcCtD
Frovatriptan—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.000167	0.000852	CcSEcCtD
Frovatriptan—Pruritus—Tacrolimus—atopic dermatitis	0.000166	0.00085	CcSEcCtD
Frovatriptan—Malaise—Prednisolone—atopic dermatitis	0.000166	0.000848	CcSEcCtD
Frovatriptan—Dysgeusia—Triamcinolone—atopic dermatitis	0.000166	0.000847	CcSEcCtD
Frovatriptan—Vertigo—Prednisolone—atopic dermatitis	0.000165	0.000845	CcSEcCtD
Frovatriptan—Syncope—Prednisolone—atopic dermatitis	0.000165	0.000844	CcSEcCtD
Frovatriptan—Back pain—Triamcinolone—atopic dermatitis	0.000164	0.000837	CcSEcCtD
Frovatriptan—Malaise—Hydrocortisone—atopic dermatitis	0.000162	0.000828	CcSEcCtD
Frovatriptan—Loss of consciousness—Prednisolone—atopic dermatitis	0.000162	0.000827	CcSEcCtD
Frovatriptan—Vertigo—Hydrocortisone—atopic dermatitis	0.000161	0.000825	CcSEcCtD
Frovatriptan—Syncope—Hydrocortisone—atopic dermatitis	0.000161	0.000824	CcSEcCtD
Frovatriptan—Diarrhoea—Tacrolimus—atopic dermatitis	0.000161	0.000822	CcSEcCtD
Frovatriptan—Convulsion—Prednisolone—atopic dermatitis	0.000159	0.000815	CcSEcCtD
Frovatriptan—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000158	0.000807	CcSEcCtD
Frovatriptan—Arrhythmia—Betamethasone—atopic dermatitis	0.000157	0.000805	CcSEcCtD
Frovatriptan—Arrhythmia—Dexamethasone—atopic dermatitis	0.000157	0.000805	CcSEcCtD
Frovatriptan—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000157	0.000803	CcSEcCtD
Frovatriptan—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000157	0.000801	CcSEcCtD
Frovatriptan—Bradycardia—Prednisone—atopic dermatitis	0.000156	0.000799	CcSEcCtD
Frovatriptan—Convulsion—Hydrocortisone—atopic dermatitis	0.000156	0.000796	CcSEcCtD
Frovatriptan—Dizziness—Tacrolimus—atopic dermatitis	0.000155	0.000795	CcSEcCtD
Frovatriptan—Discomfort—Prednisolone—atopic dermatitis	0.000155	0.000791	CcSEcCtD
Frovatriptan—Haemoglobin—Prednisone—atopic dermatitis	0.000154	0.000789	CcSEcCtD
Frovatriptan—Haemorrhage—Prednisone—atopic dermatitis	0.000154	0.000785	CcSEcCtD
Frovatriptan—Myalgia—Hydrocortisone—atopic dermatitis	0.000153	0.000782	CcSEcCtD
Frovatriptan—Malaise—Triamcinolone—atopic dermatitis	0.000153	0.00078	CcSEcCtD
Frovatriptan—Anxiety—Hydrocortisone—atopic dermatitis	0.000152	0.000779	CcSEcCtD
Frovatriptan—Malaise—Methylprednisolone—atopic dermatitis	0.000152	0.000778	CcSEcCtD
Frovatriptan—Vertigo—Triamcinolone—atopic dermatitis	0.000152	0.000777	CcSEcCtD
Frovatriptan—Syncope—Triamcinolone—atopic dermatitis	0.000152	0.000776	CcSEcCtD
Frovatriptan—Vertigo—Methylprednisolone—atopic dermatitis	0.000152	0.000775	CcSEcCtD
Frovatriptan—Syncope—Methylprednisolone—atopic dermatitis	0.000151	0.000774	CcSEcCtD
Frovatriptan—Discomfort—Hydrocortisone—atopic dermatitis	0.000151	0.000773	CcSEcCtD
Frovatriptan—Anaphylactic shock—Prednisolone—atopic dermatitis	0.00015	0.000768	CcSEcCtD
Frovatriptan—Vomiting—Tacrolimus—atopic dermatitis	0.000149	0.000764	CcSEcCtD
Frovatriptan—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000149	0.00076	CcSEcCtD
Frovatriptan—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000148	0.000759	CcSEcCtD
Frovatriptan—Shock—Prednisolone—atopic dermatitis	0.000148	0.000755	CcSEcCtD
Frovatriptan—Headache—Tacrolimus—atopic dermatitis	0.000147	0.000753	CcSEcCtD
Frovatriptan—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000147	0.00075	CcSEcCtD
Frovatriptan—Convulsion—Triamcinolone—atopic dermatitis	0.000147	0.000749	CcSEcCtD
Frovatriptan—Tachycardia—Prednisolone—atopic dermatitis	0.000146	0.000749	CcSEcCtD
Frovatriptan—Convulsion—Methylprednisolone—atopic dermatitis	0.000146	0.000748	CcSEcCtD
Frovatriptan—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000145	0.000742	CcSEcCtD
Frovatriptan—Shock—Hydrocortisone—atopic dermatitis	0.000144	0.000738	CcSEcCtD
Frovatriptan—Myalgia—Triamcinolone—atopic dermatitis	0.000144	0.000736	CcSEcCtD
Frovatriptan—Arthralgia—Methylprednisolone—atopic dermatitis	0.000144	0.000735	CcSEcCtD
Frovatriptan—Myalgia—Methylprednisolone—atopic dermatitis	0.000144	0.000735	CcSEcCtD
Frovatriptan—Anxiety—Methylprednisolone—atopic dermatitis	0.000143	0.000732	CcSEcCtD
Frovatriptan—Tachycardia—Hydrocortisone—atopic dermatitis	0.000143	0.000732	CcSEcCtD
Frovatriptan—Flushing—Prednisone—atopic dermatitis	0.000142	0.000729	CcSEcCtD
Frovatriptan—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000142	0.000728	CcSEcCtD
Frovatriptan—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000142	0.000728	CcSEcCtD
Frovatriptan—Discomfort—Triamcinolone—atopic dermatitis	0.000142	0.000728	CcSEcCtD
Frovatriptan—Discomfort—Methylprednisolone—atopic dermatitis	0.000142	0.000726	CcSEcCtD
Frovatriptan—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000142	0.000725	CcSEcCtD
Frovatriptan—Dry mouth—Triamcinolone—atopic dermatitis	0.000141	0.00072	CcSEcCtD
Frovatriptan—Anorexia—Hydrocortisone—atopic dermatitis	0.00014	0.000715	CcSEcCtD
Frovatriptan—Nausea—Tacrolimus—atopic dermatitis	0.00014	0.000714	CcSEcCtD
Frovatriptan—Confusional state—Methylprednisolone—atopic dermatitis	0.000139	0.00071	CcSEcCtD
Frovatriptan—Malaise—Betamethasone—atopic dermatitis	0.000138	0.000708	CcSEcCtD
Frovatriptan—Malaise—Dexamethasone—atopic dermatitis	0.000138	0.000708	CcSEcCtD
Frovatriptan—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000138	0.000706	CcSEcCtD
Frovatriptan—Vertigo—Betamethasone—atopic dermatitis	0.000138	0.000705	CcSEcCtD
Frovatriptan—Vertigo—Dexamethasone—atopic dermatitis	0.000138	0.000705	CcSEcCtD
Frovatriptan—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000138	0.000704	CcSEcCtD
Frovatriptan—Syncope—Betamethasone—atopic dermatitis	0.000138	0.000704	CcSEcCtD
Frovatriptan—Syncope—Dexamethasone—atopic dermatitis	0.000138	0.000704	CcSEcCtD
Frovatriptan—Arrhythmia—Prednisone—atopic dermatitis	0.000137	0.000701	CcSEcCtD
Frovatriptan—Shock—Triamcinolone—atopic dermatitis	0.000136	0.000695	CcSEcCtD
Frovatriptan—Insomnia—Prednisolone—atopic dermatitis	0.000136	0.000694	CcSEcCtD
Frovatriptan—Shock—Methylprednisolone—atopic dermatitis	0.000135	0.000693	CcSEcCtD
Frovatriptan—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000135	0.00069	CcSEcCtD
Frovatriptan—Loss of consciousness—Betamethasone—atopic dermatitis	0.000135	0.00069	CcSEcCtD
Frovatriptan—Paraesthesia—Prednisolone—atopic dermatitis	0.000135	0.000689	CcSEcCtD
Frovatriptan—Tachycardia—Triamcinolone—atopic dermatitis	0.000135	0.000689	CcSEcCtD
Frovatriptan—Mental disorder—Prednisone—atopic dermatitis	0.000134	0.000688	CcSEcCtD
Frovatriptan—Tachycardia—Methylprednisolone—atopic dermatitis	0.000134	0.000687	CcSEcCtD
Frovatriptan—Malnutrition—Prednisone—atopic dermatitis	0.000134	0.000684	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000134	0.000683	CcSEcCtD
Frovatriptan—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000133	0.000682	CcSEcCtD
Frovatriptan—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000133	0.000681	CcSEcCtD
Frovatriptan—Convulsion—Betamethasone—atopic dermatitis	0.000133	0.00068	CcSEcCtD
Frovatriptan—Convulsion—Dexamethasone—atopic dermatitis	0.000133	0.00068	CcSEcCtD
Frovatriptan—Insomnia—Hydrocortisone—atopic dermatitis	0.000133	0.000678	CcSEcCtD
Frovatriptan—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000132	0.000673	CcSEcCtD
Frovatriptan—Myalgia—Dexamethasone—atopic dermatitis	0.000131	0.000668	CcSEcCtD
Frovatriptan—Myalgia—Betamethasone—atopic dermatitis	0.000131	0.000668	CcSEcCtD
Frovatriptan—Anxiety—Dexamethasone—atopic dermatitis	0.00013	0.000666	CcSEcCtD
Frovatriptan—Anxiety—Betamethasone—atopic dermatitis	0.00013	0.000666	CcSEcCtD
Frovatriptan—Discomfort—Dexamethasone—atopic dermatitis	0.000129	0.00066	CcSEcCtD
Frovatriptan—Discomfort—Betamethasone—atopic dermatitis	0.000129	0.00066	CcSEcCtD
Frovatriptan—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000129	0.00066	CcSEcCtD
Frovatriptan—Pain—Prednisolone—atopic dermatitis	0.000128	0.000656	CcSEcCtD
Frovatriptan—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000127	0.000652	CcSEcCtD
Frovatriptan—Fatigue—Hydrocortisone—atopic dermatitis	0.000126	0.000646	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000126	0.000643	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000125	0.000642	CcSEcCtD
Frovatriptan—Pain—Hydrocortisone—atopic dermatitis	0.000125	0.000641	CcSEcCtD
Frovatriptan—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000125	0.000641	CcSEcCtD
Frovatriptan—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000125	0.000641	CcSEcCtD
Frovatriptan—Insomnia—Triamcinolone—atopic dermatitis	0.000125	0.000639	CcSEcCtD
Frovatriptan—Insomnia—Methylprednisolone—atopic dermatitis	0.000125	0.000637	CcSEcCtD
Frovatriptan—Ill-defined disorder—Prednisone—atopic dermatitis	0.000124	0.000634	CcSEcCtD
Frovatriptan—Paraesthesia—Triamcinolone—atopic dermatitis	0.000124	0.000634	CcSEcCtD
Frovatriptan—Feeling abnormal—Prednisolone—atopic dermatitis	0.000124	0.000633	CcSEcCtD
Frovatriptan—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000124	0.000633	CcSEcCtD
Frovatriptan—Shock—Dexamethasone—atopic dermatitis	0.000123	0.00063	CcSEcCtD
Frovatriptan—Shock—Betamethasone—atopic dermatitis	0.000123	0.00063	CcSEcCtD
Frovatriptan—Dyspnoea—Triamcinolone—atopic dermatitis	0.000123	0.000629	CcSEcCtD
Frovatriptan—Agitation—Prednisone—atopic dermatitis	0.000123	0.000628	CcSEcCtD
Frovatriptan—Tachycardia—Dexamethasone—atopic dermatitis	0.000122	0.000625	CcSEcCtD
Frovatriptan—Tachycardia—Betamethasone—atopic dermatitis	0.000122	0.000625	CcSEcCtD
Frovatriptan—Dyspepsia—Triamcinolone—atopic dermatitis	0.000121	0.000621	CcSEcCtD
Frovatriptan—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000121	0.00062	CcSEcCtD
Frovatriptan—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000121	0.000619	CcSEcCtD
Frovatriptan—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000121	0.000619	CcSEcCtD
Frovatriptan—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000121	0.000618	CcSEcCtD
Frovatriptan—Malaise—Prednisone—atopic dermatitis	0.000121	0.000616	CcSEcCtD
Frovatriptan—Vertigo—Prednisone—atopic dermatitis	0.00012	0.000614	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.00012	0.000613	CcSEcCtD
Frovatriptan—Syncope—Prednisone—atopic dermatitis	0.00012	0.000613	CcSEcCtD
Frovatriptan—Anorexia—Dexamethasone—atopic dermatitis	0.000119	0.000611	CcSEcCtD
Frovatriptan—Anorexia—Betamethasone—atopic dermatitis	0.000119	0.000611	CcSEcCtD
Frovatriptan—Fatigue—Triamcinolone—atopic dermatitis	0.000119	0.000609	CcSEcCtD
Frovatriptan—Fatigue—Methylprednisolone—atopic dermatitis	0.000119	0.000607	CcSEcCtD
Frovatriptan—Pain—Triamcinolone—atopic dermatitis	0.000118	0.000604	CcSEcCtD
Frovatriptan—Loss of consciousness—Prednisone—atopic dermatitis	0.000117	0.000601	CcSEcCtD
Frovatriptan—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000116	0.000593	CcSEcCtD
Frovatriptan—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000116	0.000593	CcSEcCtD
Frovatriptan—Convulsion—Prednisone—atopic dermatitis	0.000116	0.000592	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000114	0.000584	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000114	0.000584	CcSEcCtD
Frovatriptan—Arthralgia—Prednisone—atopic dermatitis	0.000114	0.000582	CcSEcCtD
Frovatriptan—Myalgia—Prednisone—atopic dermatitis	0.000114	0.000582	CcSEcCtD
Frovatriptan—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000114	0.000582	CcSEcCtD
Frovatriptan—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000113	0.00058	CcSEcCtD
Frovatriptan—Anxiety—Prednisone—atopic dermatitis	0.000113	0.00058	CcSEcCtD
Frovatriptan—Insomnia—Dexamethasone—atopic dermatitis	0.000113	0.000579	CcSEcCtD
Frovatriptan—Insomnia—Betamethasone—atopic dermatitis	0.000113	0.000579	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000113	0.000576	CcSEcCtD
Frovatriptan—Paraesthesia—Betamethasone—atopic dermatitis	0.000112	0.000575	CcSEcCtD
Frovatriptan—Paraesthesia—Dexamethasone—atopic dermatitis	0.000112	0.000575	CcSEcCtD
Frovatriptan—Discomfort—Prednisone—atopic dermatitis	0.000112	0.000575	CcSEcCtD
Frovatriptan—Hypersensitivity—Prednisolone—atopic dermatitis	0.000111	0.000566	CcSEcCtD
Frovatriptan—Dyspepsia—Dexamethasone—atopic dermatitis	0.00011	0.000564	CcSEcCtD
Frovatriptan—Dyspepsia—Betamethasone—atopic dermatitis	0.00011	0.000564	CcSEcCtD
Frovatriptan—Body temperature increased—Triamcinolone—atopic dermatitis	0.000109	0.000558	CcSEcCtD
Frovatriptan—Anaphylactic shock—Prednisone—atopic dermatitis	0.000109	0.000558	CcSEcCtD
Frovatriptan—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000109	0.000557	CcSEcCtD
Frovatriptan—Decreased appetite—Betamethasone—atopic dermatitis	0.000109	0.000557	CcSEcCtD
Frovatriptan—Decreased appetite—Dexamethasone—atopic dermatitis	0.000109	0.000557	CcSEcCtD
Frovatriptan—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000108	0.000552	CcSEcCtD
Frovatriptan—Fatigue—Betamethasone—atopic dermatitis	0.000108	0.000552	CcSEcCtD
Frovatriptan—Fatigue—Dexamethasone—atopic dermatitis	0.000108	0.000552	CcSEcCtD
Frovatriptan—Shock—Prednisone—atopic dermatitis	0.000107	0.000549	CcSEcCtD
Frovatriptan—Pain—Dexamethasone—atopic dermatitis	0.000107	0.000548	CcSEcCtD
Frovatriptan—Pain—Betamethasone—atopic dermatitis	0.000107	0.000548	CcSEcCtD
Frovatriptan—Tachycardia—Prednisone—atopic dermatitis	0.000106	0.000544	CcSEcCtD
Frovatriptan—Hyperhidrosis—Prednisone—atopic dermatitis	0.000105	0.000539	CcSEcCtD
Frovatriptan—Asthenia—Hydrocortisone—atopic dermatitis	0.000105	0.000538	CcSEcCtD
Frovatriptan—Anorexia—Prednisone—atopic dermatitis	0.000104	0.000532	CcSEcCtD
Frovatriptan—Pruritus—Hydrocortisone—atopic dermatitis	0.000104	0.00053	CcSEcCtD
Frovatriptan—Feeling abnormal—Betamethasone—atopic dermatitis	0.000103	0.000528	CcSEcCtD
Frovatriptan—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000103	0.000528	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000102	0.000524	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000102	0.000524	CcSEcCtD
Frovatriptan—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000102	0.00052	CcSEcCtD
Frovatriptan—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000101	0.000519	CcSEcCtD
Frovatriptan—Diarrhoea—Hydrocortisone—atopic dermatitis	0.0001	0.000513	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Prednisone—atopic dermatitis	9.94e-05	0.000508	CcSEcCtD
Frovatriptan—Dizziness—Prednisolone—atopic dermatitis	9.93e-05	0.000508	CcSEcCtD
Frovatriptan—Asthenia—Triamcinolone—atopic dermatitis	9.9e-05	0.000507	CcSEcCtD
Frovatriptan—Abdominal pain—Dexamethasone—atopic dermatitis	9.9e-05	0.000506	CcSEcCtD
Frovatriptan—Body temperature increased—Betamethasone—atopic dermatitis	9.9e-05	0.000506	CcSEcCtD
Frovatriptan—Abdominal pain—Betamethasone—atopic dermatitis	9.9e-05	0.000506	CcSEcCtD
Frovatriptan—Body temperature increased—Dexamethasone—atopic dermatitis	9.9e-05	0.000506	CcSEcCtD
Frovatriptan—Asthenia—Methylprednisolone—atopic dermatitis	9.88e-05	0.000505	CcSEcCtD
Frovatriptan—Insomnia—Prednisone—atopic dermatitis	9.86e-05	0.000505	CcSEcCtD
Frovatriptan—Paraesthesia—Prednisone—atopic dermatitis	9.79e-05	0.000501	CcSEcCtD
Frovatriptan—Pruritus—Triamcinolone—atopic dermatitis	9.77e-05	0.000499	CcSEcCtD
Frovatriptan—Pruritus—Methylprednisolone—atopic dermatitis	9.74e-05	0.000498	CcSEcCtD
Frovatriptan—Dizziness—Hydrocortisone—atopic dermatitis	9.69e-05	0.000496	CcSEcCtD
Frovatriptan—Dyspepsia—Prednisone—atopic dermatitis	9.6e-05	0.000491	CcSEcCtD
Frovatriptan—Decreased appetite—Prednisone—atopic dermatitis	9.48e-05	0.000485	CcSEcCtD
Frovatriptan—Diarrhoea—Methylprednisolone—atopic dermatitis	9.42e-05	0.000482	CcSEcCtD
Frovatriptan—Fatigue—Prednisone—atopic dermatitis	9.4e-05	0.000481	CcSEcCtD
Frovatriptan—Headache—Prednisolone—atopic dermatitis	9.4e-05	0.000481	CcSEcCtD
Frovatriptan—Constipation—Prednisone—atopic dermatitis	9.33e-05	0.000477	CcSEcCtD
Frovatriptan—Vomiting—Hydrocortisone—atopic dermatitis	9.32e-05	0.000477	CcSEcCtD
Frovatriptan—Headache—Hydrocortisone—atopic dermatitis	9.18e-05	0.00047	CcSEcCtD
Frovatriptan—Dizziness—Triamcinolone—atopic dermatitis	9.13e-05	0.000467	CcSEcCtD
Frovatriptan—Dizziness—Methylprednisolone—atopic dermatitis	9.11e-05	0.000466	CcSEcCtD
Frovatriptan—Feeling abnormal—Prednisone—atopic dermatitis	8.99e-05	0.00046	CcSEcCtD
Frovatriptan—Asthenia—Dexamethasone—atopic dermatitis	8.99e-05	0.00046	CcSEcCtD
Frovatriptan—Asthenia—Betamethasone—atopic dermatitis	8.99e-05	0.00046	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Prednisone—atopic dermatitis	8.92e-05	0.000456	CcSEcCtD
Frovatriptan—Nausea—Prednisolone—atopic dermatitis	8.92e-05	0.000456	CcSEcCtD
Frovatriptan—Pruritus—Betamethasone—atopic dermatitis	8.86e-05	0.000453	CcSEcCtD
Frovatriptan—Pruritus—Dexamethasone—atopic dermatitis	8.86e-05	0.000453	CcSEcCtD
Frovatriptan—Vomiting—Triamcinolone—atopic dermatitis	8.78e-05	0.000449	CcSEcCtD
Frovatriptan—Vomiting—Methylprednisolone—atopic dermatitis	8.76e-05	0.000448	CcSEcCtD
Frovatriptan—Nausea—Hydrocortisone—atopic dermatitis	8.71e-05	0.000445	CcSEcCtD
Frovatriptan—Headache—Triamcinolone—atopic dermatitis	8.65e-05	0.000442	CcSEcCtD
Frovatriptan—Headache—Methylprednisolone—atopic dermatitis	8.63e-05	0.000441	CcSEcCtD
Frovatriptan—Abdominal pain—Prednisone—atopic dermatitis	8.62e-05	0.000441	CcSEcCtD
Frovatriptan—Body temperature increased—Prednisone—atopic dermatitis	8.62e-05	0.000441	CcSEcCtD
Frovatriptan—Diarrhoea—Dexamethasone—atopic dermatitis	8.57e-05	0.000438	CcSEcCtD
Frovatriptan—Diarrhoea—Betamethasone—atopic dermatitis	8.57e-05	0.000438	CcSEcCtD
Frovatriptan—Dizziness—Betamethasone—atopic dermatitis	8.28e-05	0.000424	CcSEcCtD
Frovatriptan—Dizziness—Dexamethasone—atopic dermatitis	8.28e-05	0.000424	CcSEcCtD
Frovatriptan—Nausea—Triamcinolone—atopic dermatitis	8.2e-05	0.000419	CcSEcCtD
Frovatriptan—Nausea—Methylprednisolone—atopic dermatitis	8.18e-05	0.000418	CcSEcCtD
Frovatriptan—Hypersensitivity—Prednisone—atopic dermatitis	8.04e-05	0.000411	CcSEcCtD
Frovatriptan—Vomiting—Betamethasone—atopic dermatitis	7.96e-05	0.000407	CcSEcCtD
Frovatriptan—Vomiting—Dexamethasone—atopic dermatitis	7.96e-05	0.000407	CcSEcCtD
Frovatriptan—Headache—Dexamethasone—atopic dermatitis	7.85e-05	0.000401	CcSEcCtD
Frovatriptan—Headache—Betamethasone—atopic dermatitis	7.85e-05	0.000401	CcSEcCtD
Frovatriptan—Asthenia—Prednisone—atopic dermatitis	7.83e-05	0.0004	CcSEcCtD
Frovatriptan—Pruritus—Prednisone—atopic dermatitis	7.72e-05	0.000395	CcSEcCtD
Frovatriptan—Diarrhoea—Prednisone—atopic dermatitis	7.46e-05	0.000382	CcSEcCtD
Frovatriptan—Nausea—Dexamethasone—atopic dermatitis	7.44e-05	0.00038	CcSEcCtD
Frovatriptan—Nausea—Betamethasone—atopic dermatitis	7.44e-05	0.00038	CcSEcCtD
Frovatriptan—Dizziness—Prednisone—atopic dermatitis	7.21e-05	0.000369	CcSEcCtD
Frovatriptan—Vomiting—Prednisone—atopic dermatitis	6.93e-05	0.000355	CcSEcCtD
Frovatriptan—Headache—Prednisone—atopic dermatitis	6.83e-05	0.000349	CcSEcCtD
Frovatriptan—Nausea—Prednisone—atopic dermatitis	6.48e-05	0.000331	CcSEcCtD
Frovatriptan—HTR1D—G alpha (i) signalling events—CCR3—atopic dermatitis	5.58e-05	0.00926	CbGpPWpGaD
Frovatriptan—HTR1B—G alpha (i) signalling events—CCR3—atopic dermatitis	5.46e-05	0.00906	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	5.44e-05	0.00903	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	5.32e-05	0.00884	CbGpPWpGaD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	5.17e-05	0.00859	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—TAC1—atopic dermatitis	5.14e-05	0.00854	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CCL17—atopic dermatitis	5.14e-05	0.00853	CbGpPWpGaD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	5.07e-05	0.00841	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	5.03e-05	0.00835	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CCL17—atopic dermatitis	5.03e-05	0.00835	CbGpPWpGaD
Frovatriptan—HTR1D—G alpha (i) signalling events—CXCR3—atopic dermatitis	4.87e-05	0.00809	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CCL22—atopic dermatitis	4.79e-05	0.00796	CbGpPWpGaD
Frovatriptan—HTR1B—G alpha (i) signalling events—CXCR3—atopic dermatitis	4.77e-05	0.00792	CbGpPWpGaD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	4.52e-05	0.00751	CbGpPWpGaD
Frovatriptan—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	4.45e-05	0.00739	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	4.43e-05	0.00736	CbGpPWpGaD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	4.43e-05	0.00735	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	4.34e-05	0.00721	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CCL27—atopic dermatitis	4.27e-05	0.00709	CbGpPWpGaD
Frovatriptan—HTR1A—G alpha (i) signalling events—CCR3—atopic dermatitis	4.16e-05	0.0069	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CCL11—atopic dermatitis	4.14e-05	0.00687	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	4.06e-05	0.00673	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CCL11—atopic dermatitis	4.05e-05	0.00673	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	3.95e-05	0.00656	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	3.95e-05	0.00656	CbGpPWpGaD
Frovatriptan—HTR1D—G alpha (i) signalling events—CXCL10—atopic dermatitis	3.94e-05	0.00654	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	3.87e-05	0.00643	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	3.87e-05	0.00642	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	3.87e-05	0.00642	CbGpPWpGaD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	3.86e-05	0.00641	CbGpPWpGaD
Frovatriptan—HTR1B—G alpha (i) signalling events—CXCL10—atopic dermatitis	3.86e-05	0.0064	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CCL17—atopic dermatitis	3.83e-05	0.00636	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	3.79e-05	0.0063	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—BDNF—atopic dermatitis	3.66e-05	0.00608	CbGpPWpGaD
Frovatriptan—HTR1A—G alpha (i) signalling events—CXCR3—atopic dermatitis	3.64e-05	0.00603	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—IL10—atopic dermatitis	3.5e-05	0.00581	CbGpPWpGaD
Frovatriptan—HTR1D—G alpha (i) signalling events—CCL5—atopic dermatitis	3.39e-05	0.00563	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CCR3—atopic dermatitis	3.38e-05	0.0056	CbGpPWpGaD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	3.37e-05	0.0056	CbGpPWpGaD
Frovatriptan—HTR1B—G alpha (i) signalling events—CCL5—atopic dermatitis	3.32e-05	0.00551	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	3.31e-05	0.00549	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CCR3—atopic dermatitis	3.31e-05	0.00549	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCL22—atopic dermatitis	3.3e-05	0.00547	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—NGF—atopic dermatitis	3.25e-05	0.0054	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CCL27—atopic dermatitis	3.24e-05	0.00537	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCL22—atopic dermatitis	3.23e-05	0.00536	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CCL27—atopic dermatitis	3.17e-05	0.00526	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	3.13e-05	0.0052	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CCL11—atopic dermatitis	3.09e-05	0.00513	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	3.07e-05	0.00509	CbGpPWpGaD
Frovatriptan—HTR1D—G alpha (i) signalling events—CCR5—atopic dermatitis	3.05e-05	0.00507	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—NPS—atopic dermatitis	3.01e-05	0.00499	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—TAC1—atopic dermatitis	3.01e-05	0.00499	CbGpPWpGaD
Frovatriptan—HTR1B—G alpha (i) signalling events—CCR5—atopic dermatitis	2.99e-05	0.00497	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CXCR3—atopic dermatitis	2.95e-05	0.0049	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	2.95e-05	0.00489	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	2.95e-05	0.00489	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—NPS—atopic dermatitis	2.95e-05	0.00489	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—TAC1—atopic dermatitis	2.95e-05	0.00489	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCL27—atopic dermatitis	2.94e-05	0.00488	CbGpPWpGaD
Frovatriptan—HTR1A—G alpha (i) signalling events—CXCL10—atopic dermatitis	2.94e-05	0.00488	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	2.89e-05	0.0048	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CXCR3—atopic dermatitis	2.89e-05	0.0048	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCL27—atopic dermatitis	2.88e-05	0.00478	CbGpPWpGaD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	2.83e-05	0.00471	CbGpPWpGaD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	2.78e-05	0.00461	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	2.7e-05	0.00448	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	2.64e-05	0.00438	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCL17—atopic dermatitis	2.64e-05	0.00438	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCL17—atopic dermatitis	2.58e-05	0.00429	CbGpPWpGaD
Frovatriptan—HTR1A—G alpha (i) signalling events—CCL5—atopic dermatitis	2.53e-05	0.0042	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CCR3—atopic dermatitis	2.52e-05	0.00418	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCL22—atopic dermatitis	2.46e-05	0.00408	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.43e-05	0.00403	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CCL27—atopic dermatitis	2.41e-05	0.00401	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CXCL10—atopic dermatitis	2.39e-05	0.00396	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.38e-05	0.00395	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	2.37e-05	0.00393	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	2.34e-05	0.00388	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CXCL10—atopic dermatitis	2.34e-05	0.00388	CbGpPWpGaD
Frovatriptan—HTR1A—G alpha (i) signalling events—CCR5—atopic dermatitis	2.28e-05	0.00378	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—TAC1—atopic dermatitis	2.24e-05	0.00373	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—NPS—atopic dermatitis	2.24e-05	0.00373	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CXCR3—atopic dermatitis	2.2e-05	0.00365	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCL27—atopic dermatitis	2.19e-05	0.00364	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCL11—atopic dermatitis	2.13e-05	0.00353	CbGpPWpGaD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	2.11e-05	0.00351	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	2.11e-05	0.00351	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	2.11e-05	0.0035	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FCER2—atopic dermatitis	2.1e-05	0.00348	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCL11—atopic dermatitis	2.08e-05	0.00345	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CCL5—atopic dermatitis	2.05e-05	0.00341	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FCER2—atopic dermatitis	2.05e-05	0.00341	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	2.01e-05	0.00334	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CCL5—atopic dermatitis	2.01e-05	0.00334	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCL17—atopic dermatitis	1.97e-05	0.00326	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCL22—atopic dermatitis	1.95e-05	0.00323	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	1.91e-05	0.00317	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CCR3—atopic dermatitis	1.91e-05	0.00317	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCL22—atopic dermatitis	1.91e-05	0.00317	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CCR3—atopic dermatitis	1.87e-05	0.0031	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CCR5—atopic dermatitis	1.85e-05	0.00307	CbGpPWpGaD
Frovatriptan—HTR1D—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.85e-05	0.00307	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	1.83e-05	0.00304	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.81e-05	0.00301	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CCR5—atopic dermatitis	1.81e-05	0.00301	CbGpPWpGaD
Frovatriptan—HTR1B—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.81e-05	0.003	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CXCL10—atopic dermatitis	1.78e-05	0.00295	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCL27—atopic dermatitis	1.74e-05	0.00288	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCR3—atopic dermatitis	1.73e-05	0.00288	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—TAC1—atopic dermatitis	1.7e-05	0.00282	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—NPS—atopic dermatitis	1.7e-05	0.00282	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCL27—atopic dermatitis	1.7e-05	0.00282	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCR3—atopic dermatitis	1.7e-05	0.00282	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CXCR3—atopic dermatitis	1.67e-05	0.00277	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—TAC1—atopic dermatitis	1.66e-05	0.00276	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—NPS—atopic dermatitis	1.66e-05	0.00276	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CXCR3—atopic dermatitis	1.63e-05	0.00271	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCL11—atopic dermatitis	1.59e-05	0.00263	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—IL5—atopic dermatitis	1.58e-05	0.00262	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FCER2—atopic dermatitis	1.56e-05	0.00259	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCL17—atopic dermatitis	1.56e-05	0.00259	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—IL5—atopic dermatitis	1.55e-05	0.00257	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—TAC1—atopic dermatitis	1.54e-05	0.00256	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—NPS—atopic dermatitis	1.54e-05	0.00256	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	1.53e-05	0.00255	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	1.53e-05	0.00255	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CCL5—atopic dermatitis	1.53e-05	0.00254	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCL17—atopic dermatitis	1.52e-05	0.00253	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CXCR3—atopic dermatitis	1.51e-05	0.00251	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—TAC1—atopic dermatitis	1.51e-05	0.00251	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—NPS—atopic dermatitis	1.51e-05	0.00251	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CXCR3—atopic dermatitis	1.48e-05	0.00246	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.47e-05	0.00244	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL22—atopic dermatitis	1.45e-05	0.00241	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	1.44e-05	0.00239	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.44e-05	0.00239	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL5—atopic dermatitis	1.44e-05	0.00238	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CCR3—atopic dermatitis	1.42e-05	0.00236	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL5—atopic dermatitis	1.41e-05	0.00233	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—KIF3A—atopic dermatitis	1.39e-05	0.0023	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CCR5—atopic dermatitis	1.38e-05	0.00229	CbGpPWpGaD
Frovatriptan—HTR1A—G alpha (i) signalling events—CXCL8—atopic dermatitis	1.38e-05	0.00229	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—KIF3A—atopic dermatitis	1.36e-05	0.00226	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CXCL10—atopic dermatitis	1.35e-05	0.00224	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—atopic dermatitis	1.33e-05	0.00221	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CXCL10—atopic dermatitis	1.32e-05	0.00219	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL27—atopic dermatitis	1.3e-05	0.00215	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCR3—atopic dermatitis	1.29e-05	0.00215	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—NPS—atopic dermatitis	1.27e-05	0.00211	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—TAC1—atopic dermatitis	1.27e-05	0.00211	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCL11—atopic dermatitis	1.26e-05	0.00208	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CMA1—atopic dermatitis	1.26e-05	0.00208	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CXCR3—atopic dermatitis	1.24e-05	0.00206	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCL11—atopic dermatitis	1.23e-05	0.00204	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CMA1—atopic dermatitis	1.23e-05	0.00204	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CXCL10—atopic dermatitis	1.22e-05	0.00203	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CXCL10—atopic dermatitis	1.2e-05	0.00199	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—STAT6—atopic dermatitis	1.18e-05	0.00196	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—IL5—atopic dermatitis	1.18e-05	0.00196	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL17—atopic dermatitis	1.16e-05	0.00193	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CCL5—atopic dermatitis	1.16e-05	0.00193	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—STAT6—atopic dermatitis	1.16e-05	0.00192	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—NPS—atopic dermatitis	1.15e-05	0.00191	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—TAC1—atopic dermatitis	1.15e-05	0.00191	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CCL5—atopic dermatitis	1.14e-05	0.00189	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CXCR3—atopic dermatitis	1.13e-05	0.00188	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—CXCL8—atopic dermatitis	1.12e-05	0.00186	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.1e-05	0.00182	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—CXCL8—atopic dermatitis	1.09e-05	0.00182	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.07e-05	0.00178	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL5—atopic dermatitis	1.07e-05	0.00178	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCL5—atopic dermatitis	1.05e-05	0.00175	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CCR5—atopic dermatitis	1.05e-05	0.00174	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—KIF3A—atopic dermatitis	1.04e-05	0.00172	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCL5—atopic dermatitis	1.03e-05	0.00171	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CCR5—atopic dermatitis	1.02e-05	0.0017	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCR3—atopic dermatitis	1.02e-05	0.0017	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CXCL10—atopic dermatitis	1.01e-05	0.00167	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCR3—atopic dermatitis	1e-05	0.00166	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CCR5—atopic dermatitis	9.49e-06	0.00158	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CMA1—atopic dermatitis	9.36e-06	0.00155	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL11—atopic dermatitis	9.36e-06	0.00155	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CCR5—atopic dermatitis	9.29e-06	0.00154	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CXCL10—atopic dermatitis	9.13e-06	0.00152	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NPS—atopic dermatitis	9.12e-06	0.00151	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TAC1—atopic dermatitis	9.12e-06	0.00151	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CXCR3—atopic dermatitis	8.95e-06	0.00148	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NPS—atopic dermatitis	8.93e-06	0.00148	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TAC1—atopic dermatitis	8.93e-06	0.00148	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—STAT6—atopic dermatitis	8.8e-06	0.00146	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CXCR3—atopic dermatitis	8.76e-06	0.00145	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CCL5—atopic dermatitis	8.65e-06	0.00144	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL5—atopic dermatitis	8.48e-06	0.00141	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—CXCL8—atopic dermatitis	8.34e-06	0.00138	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL5—atopic dermatitis	8.3e-06	0.00138	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCL5—atopic dermatitis	7.86e-06	0.0013	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CCR5—atopic dermatitis	7.8e-06	0.00129	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCR3—atopic dermatitis	7.63e-06	0.00127	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CXCL10—atopic dermatitis	7.23e-06	0.0012	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CCR5—atopic dermatitis	7.08e-06	0.00118	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CXCL10—atopic dermatitis	7.08e-06	0.00118	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NPS—atopic dermatitis	6.8e-06	0.00113	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TAC1—atopic dermatitis	6.8e-06	0.00113	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCR3—atopic dermatitis	6.67e-06	0.00111	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GLB1—atopic dermatitis	6.41e-06	0.00106	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL5—atopic dermatitis	6.33e-06	0.00105	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—CXCL8—atopic dermatitis	6.32e-06	0.00105	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCL5—atopic dermatitis	6.22e-06	0.00103	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—CXCL8—atopic dermatitis	6.19e-06	0.00103	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ADSL—atopic dermatitis	6.15e-06	0.00102	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCL5—atopic dermatitis	6.09e-06	0.00101	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—IL2—atopic dermatitis	6.04e-06	0.001	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—IL2—atopic dermatitis	5.91e-06	0.000982	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NGF—atopic dermatitis	5.76e-06	0.000957	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—CXCL8—atopic dermatitis	5.74e-06	0.000953	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NGF—atopic dermatitis	5.64e-06	0.000937	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—CXCL8—atopic dermatitis	5.62e-06	0.000933	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CCR5—atopic dermatitis	5.61e-06	0.000931	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	5.49e-06	0.000911	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL2—atopic dermatitis	5.48e-06	0.00091	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	5.39e-06	0.000895	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	5.37e-06	0.000891	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	4.75e-06	0.000789	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	4.71e-06	0.000783	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.67e-06	0.000776	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	4.65e-06	0.000773	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	4.64e-06	0.000771	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	4.5e-06	0.000748	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NGF—atopic dermatitis	4.3e-06	0.000714	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	4.28e-06	0.000711	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	4.18e-06	0.000694	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	4.09e-06	0.000679	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	3.55e-06	0.000589	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	3.39e-06	0.000563	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	3.32e-06	0.000551	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL2—atopic dermatitis	3.24e-06	0.000538	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	3.22e-06	0.000535	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL2—atopic dermatitis	3.17e-06	0.000527	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	3.16e-06	0.000524	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	2.98e-06	0.000495	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	2.92e-06	0.000485	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	2.53e-06	0.00042	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL2—atopic dermatitis	2.42e-06	0.000401	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	2.4e-06	0.000399	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	2.22e-06	0.000369	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PPARA—atopic dermatitis	2.08e-06	0.000345	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6—atopic dermatitis	1.9e-06	0.000316	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6—atopic dermatitis	1.86e-06	0.00031	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6—atopic dermatitis	1.42e-06	0.000236	CbGpPWpGaD
